Table 3.

Estimated HCV antibody and RNA positivity among Phetchabun residents

District	% Anti-HCV	% HCV RNA	Target population*			Estimated HCV-seropositive population			Estimated HCV viremic population
	Male/female	Male/female	Male	Female	Total	Male	Female	Total	Male	Female	Total
1	22.6/3.9	86.9/74.2	46,105	49,999	96,104	10,420	1,950	12,370	9,053	1,447	10,500
2	7.4/2.7	80.0/50.0	17,796	18,241	36,037	1,317	493	1,809	1,054	246	1,300
3	29.1/4.2	81.0/66.7	35,014	37,266	72,280	10,189	1,565	11,754	8,248	1,043	9,291
4	22.7/4.4	94.1/70.0	14,887	15,307	30,194	3,379	674	4,053	3,181	471	3,652
5	4.7/1.4	75.0/50.0	29,389	30,967	60,356	1,381	434	1,815	1,036	217	1,253
6	1.2/1.6	0.0/50.0	15,658	16,373	32,031	188	262	450	0	131	131
7	11.6/2	70.6/50.0	25,372	26,175	51,547	2,943	524	3,467	2,078	262	2,340
8	0.9/0.8	0.0/50.0	15,977	16,736	32,713	144	134	278	0	67	67
9	10.7/4.9	66.7/33.3	4,449	4,130	8,579	476	202	678	317	67	384
10	2.8/2.7	100.0/0.0	8,580	8,876	17,456	240	240	480	240	0	240
11	17.0/2.0	77.8/100.0	7,080	7,254	14,334	1,204	145	1,349	936	145	1,081
Total	15.9/2.8	81.5/61.7	220,307	231,324	451,631	31,881	6,621	38,502	26,143	4,096	30,239

HCV = hepatitis C virus.

^*Target population data were extrapolated from the 2019 population census registry (for age 35–65 years) (cited: September 20, 2019).¹¹